- 询价
- Abcam
- 中国/美国/德国
- xy10542-RP01
- 2025年07月14日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
常温，避光
- 克隆性：
单克隆
- 抗体名：
VEGF-C / Flt4-L / VRP抗体
抗体类型: Rabbit Polyclonal Antibody ( Antibody Purification Platform )
抗体宿主 : Rabbit IgG
缓冲液 : 0.2 μm filtered solution in PBS, 5% trehalose may be added in some batches. Please read the hardcopy of COA or contact our customer service to confirm the formulation.
制备方法 : Produced in rabbits immunized with purified, human cell-derived, recombinant human VEGF-C ( rh VEGF-C ; Catalog#10542-H08H ; NP_005420.1 ; Thr 103 - Arg 227 ). Total IgG was purified by Protein A affinity chromatography.
VEGF-C / Flt4-L / VRP抗体背景综述
Vascular endothelial growth factor (VEGF)-C is a member of the VEGF family, a group of polypeptide growth factors which play key roles in the physiology and pathology of many aspects of the cardiovascular system, including vasculogenesis, hematopoiesis, angiogenesis and vascular permeability. While VEGFC is homologous to other members of the VEGF/PDGF family, it contains the C-terminal propeptide which has an unusual structure with tandemly repeated cysteine-rich motifs. Upon biosynthesis, VEGFC is secreted as a non-covalent momodimer in an anti-parellel fashion. VEGF signalling in endothelial cells occurs through three tyrosine kinase receptors (VEGFRs) expressed by endothelial cells and hematopoietic precursors, and VEGF-C is a ligand for two receptors, VEGFR-3 (Flt4), and VEGFR-2. It is indicated that VEGFC undergoes a complex proteolytic maturation generating a variety of processed secreted forms with increased activity toward VEGFR-3, but only the fully processed form could activate VEGFR-2. VEGFC may function in angiogenesis of the venous and lymphatic vascular systems during embryogenesis, and also in the maintenance of differentiated lymphatic endothelium in adults.
VEGF-C / Flt4-L / VRP抗体相关产品如下：xy-0820R EBNA 3AEB病毒核抗原-3A抗体
xy-1003R EAAT1胶质细胞谷氨酸运载蛋白1抗体
xy-0599R E2F1转录因子E2F-1抗体
xy-1190R ECE1内皮素转化酶1抗体
xy-0776R ECM1细胞外基质蛋白1抗体
xy-1149R ED-1外胚层发育不良抗体
xy-2071R E2 tagE2 tag标签抗体
xy-9521R FECH铁螯合酶抗体
xy-2033R E.coli DH-5 AlphaDH5α大肠杆菌菌体蛋白抗体
xy-1522R phospho-ERK1 + 2 (Thr183/185)磷酸化丝裂原活化蛋白激酶1/2抗体
xy-1513R EpCAM上皮细胞粘附分子抗体
xy-0996R EphB2酪氨酸蛋白激酶受体B2抗体
xy-2008R EGF表皮生长因子抗体
xy-1454R ErbB 3表皮生长因子受体3抗体
xy-1455R EphA4 R酪氨酸蛋白激酶A4受体抗体
xy-1519R E cadherin上皮钙粘附分子抗体
xy-1424R EPOR红细胞生成素受体抗体
xy-2106R Enkephalin脑啡肽抗体
xy-13761R EID2EID2蛋白抗体
xy-4889R EpCAM上皮细胞粘附分子抗体
xy-12333R ERMAP红细胞膜相关蛋白ERMAP抗体
xy-2279R EMC1腺样癌特异性相关抗原EMC1抗体
xym-2279M EMC1腺样癌特异性相关抗原EMC1抗体
xy-12360R Epiphycan硫酸软骨素蛋白多糖3抗体
xy-10151R Exportin 1/CRM1染色体区域稳定蛋白/核输出蛋白1抗体
xy-10154R Phospho-ELk1(Ser383)磷酸化细胞转录因子ELK1抗体
xy-12341R ETV2ETS相关蛋白71抗体
xy-12347R EDA外胚层发育不良蛋白1抗体
xy-13114R ETV3LETV3L蛋白抗体
xy-2571R EphB6酪氨酸蛋白激酶受体B6抗体
xy-2880R LPA1溶血磷脂酸受体蛋白1抗体
xy-2881R LPA2溶血磷脂酸受体蛋白2抗体
xy-2882R LPA3溶血磷脂酸受体蛋白3抗体
xy-2883R EDG6内皮细胞的分化蛋白6抗体
xy-6005R EXTL2外生性骨疣样蛋白2抗体
xy-5334R phospho-EIF4EBP1 (Ser100)磷酸化eIF4E结合蛋白抗体
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Clonality - X Chromosome Inactivation Assay
can utilize X chromosome inactivation (methylation) to determine the clonality status of a tumor or premalignant lesion in females. The technique is based on a methylation-sensitive restriction enzyme and analysis of a polymorphic locus on the X chromosome
人转录因子E2F1 ( E2F1 )ELISA 试剂盒 原理 本实验采用双抗体夹心 ABC-ELISA 法。用抗人 E2F1 单抗包被于酶标板上，标准品和样品中的 E2F1与单抗结合，加入生物素化的抗人 E2F1 ，形成免疫复合物连接在板上，辣根过氧化物酶标记的 Streptavidin 与生物素结合，加入底物工作液显蓝色，最后加终止液硫酸，在 450nm 处测 OD 值，E2F1 浓度与 OD 值成正比
X性联无丙种球蛋白血症(X-linked agammagl，bulinemia，XLA)是临床上首次确定的体液免疫缺陷病，由Brutor于1952年报道，故又称Bruton病。XLA作为常见的原发性免疫缺陷病之一，特点为血清中各类免疫球蛋白缺乏，或只能测得微量的抗体。外周血和淋巴组织中B细胞减少或完全缺乏，淋巴结中无生发中心和浆细胞。本病起病早，在出生数月后当患儿体内的母源性抗体水平下降时开始发病。临床表现为反复化脓性感染，患者细胞免疫功能不受影响(部分患者有T细胞数量减少)，主要缺陷
技术资料暂无技术资料 索取技术资料
